ロード中...
Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
A debate about the market-leading influenza antiviral medication, oseltamivir, which initially focused on treatment for generally mild illness, has been expanded to question the wisdom of stockpiling for use in future influenza pandemics. Although randomized controlled trial evidence confirms that o...
保存先:
| 出版年: | Emerg Infect Dis |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Centers for Disease Control and Prevention
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4880079/ https://ncbi.nlm.nih.gov/pubmed/27191818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2206.151037 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|